Survival of patients with advanced melanoma according to first-line treatment and key prognostic factors: Real-world data from GEM1801 study

Marquez-Rodas, I.Berciano Guerrero, M. A.Munoz Couselo, E.Manzano, J. L.Crespo Herrero, G.Soria, A.Cerezuela, P.Puertolas Hernandez, T.Berrocal, A.Majem Tarruella, M.Bellido Hernandez, L.Espinosa, E.Garcia Castano, A.Medina Martinez, J.Fernandez Morales, L. A.Aguado de la Rosa, C.Gutierrez Sanz, L.Lopez Castro, R.Ayala de Miguel, P.Martin Algarra, S.2025-01-072025-01-072021-09-210923-7534https://hdl.handle.net/10668/26995enSurvival of patients with advanced melanoma according to first-line treatment and key prognostic factors: Real-world data from GEM1801 studyconference outputopen access10.1016/j.annonc.2021.08.14411569-8041https://doi.org/10.1016/j.annonc.2021.08.1441700527702074